Government on Tuesday cleared the Rs 5,168-crore deal of the US-based Mylan Inc for acquiring Bangalore-based pharma firm Agila Specialties, a subsidiary of Strides Arcolab. After completion of acquisition process, Mylan has been asked to maintain the investment level in R&D in value terms for 5-years at absolute quantitative level at the time of induction of FDI, according to sources.